Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

TCR stimulation drives cleavage and shedding of the ITIM receptor CD31.

Fornasa G, Groyer E, Clement M, Dimitrov J, Compain C, Gaston AT, Varthaman A, Khallou-Laschet J, Newman DK, Graff-Dubois S, Nicoletti A, Caligiuri G.

J Immunol. 2010 May 15;184(10):5485-92. doi: 10.4049/jimmunol.0902219. Epub 2010 Apr 16.

2.

The anti-inflammatory actions of platelet endothelial cell adhesion molecule-1 do not involve regulation of endothelial cell NF-kappa B.

Privratsky JR, Tourdot BE, Newman DK, Newman PJ.

J Immunol. 2010 Mar 15;184(6):3157-63. doi: 10.4049/jimmunol.0901944. Epub 2010 Feb 19.

3.

MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation.

O'Reilly LA, Kruse EA, Puthalakath H, Kelly PN, Kaufmann T, Huang DC, Strasser A.

J Immunol. 2009 Jul 1;183(1):261-9. doi: 10.4049/jimmunol.0803853.

4.

Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection.

Picca CC, Larkin J 3rd, Boesteanu A, Lerman MA, Rankin AL, Caton AJ.

Immunol Rev. 2006 Aug;212:74-85. Review.

PMID:
16903907
5.

Mechanisms of PECAM-1-mediated cytoprotection and implications for cancer cell survival.

Bergom C, Gao C, Newman PJ.

Leuk Lymphoma. 2005 Oct;46(10):1409-21. Review.

PMID:
16194886
6.

The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis.

Wong MX, Hayball JD, Hogarth PM, Jackson DE.

J Clin Immunol. 2005 Jan;25(1):19-28.

PMID:
15742154
7.

Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice.

Carrithers M, Tandon S, Canosa S, Michaud M, Graesser D, Madri JA.

Am J Pathol. 2005 Jan;166(1):185-96.

8.

Transplantation tolerance induced by intranasal administration of HY peptides.

Chai JG, James E, Dewchand H, Simpson E, Scott D.

Blood. 2004 May 15;103(10):3951-9. Epub 2004 Jan 15.

9.

Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1.

Tada Y, Koarada S, Morito F, Ushiyama O, Haruta Y, Kanegae F, Ohta A, Ho A, Mak TW, Nagasawa K.

Arthritis Rheum. 2003 Nov;48(11):3280-90.

10.
11.

Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology.

Newman PJ, Newman DK.

Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):953-64. Epub 2003 Apr 10. Review.

12.

PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis.

Gao C, Sun W, Christofidou-Solomidou M, Sawada M, Newman DK, Bergom C, Albelda SM, Matsuyama S, Newman PJ.

Blood. 2003 Jul 1;102(1):169-79. Epub 2003 Mar 20.

13.

Platelet-endothelial cell adhesion molecule-1 (CD31) expression on donor endothelial cells attenuates the development of transplant arteriosclerosis.

Ensminger SM, Spriewald BM, Steger U, Morris PJ, Mak TW, Wood KJ.

Transplantation. 2002 Nov 15;74(9):1267-73.

PMID:
12451264
14.
16.

Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice.

Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, Davis S, Ruddle NH, Engelhardt B, Madri JA.

J Clin Invest. 2002 Feb;109(3):383-92.

18.
19.

Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions.

Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H, Spellberg J, de la Pompa JL, Elia A, Wakeham A, Karan-Tamir B, Muller WA, Senaldi G, Zukowski MM, Mak TW.

J Immunol. 1999 Mar 1;162(5):3022-30.

20.

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Lutz MB, Kukutsch N, Ogilvie AL, Rössner S, Koch F, Romani N, Schuler G.

J Immunol Methods. 1999 Feb 1;223(1):77-92.

PMID:
10037236

Supplemental Content

Support Center